Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jianming Xing has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cryptotanshinone Alleviates Cardiac Hypertrophy Through SIRT3-Mediated Epigenetic Regulation and Mitochondrial Dynamics

    by Jianming Xing, Peng Ji, Xintong Gu, Shuoxi Guo, Meilun Wang, Xushuang Jia, Jiaqi Chen, Junjie Chang, Xiaohan Cui, Ye Jin, et al.

    Cryptotanshinone (CTS), a bioactive diterpenoid extracted from Salvia miltiorrhiza Bunge, has long been recognized as a traditional Chinese herbal compound. This study reveals that CTS exerts potent anti-hypertrophic effects against angiotensin II (Ang II)-induced cardiac hypertrophy by targeting Sirtuin 3 (SIRT3)-mediated epigenetic and mitochondrial pathways. In both in vitro and in vivo models, CTS ameliorated pathological hypertrophy, oxidative stress, inflammation, and apoptosis. Mechanistically, CTS upregulated SIRT3, reducing histone H3K9 acetylation (H3K9ac) and restoring mitochondrial dynamics by balancing fission (DRP1) and fusion (MFN2) proteins. Genetic ablation of SIRT3 exacerbated hypertrophy and mitochondrial dysfunction, while pharmacological inhibition with 3-TYP abolished CTS benefits. These findings elucidate CTS as a therapeutic candidate for cardiac hypertrophy by activating SIRT3, which is accompanied by reduced H3K9ac and restored DRP1/MFN2 balance, highlighting potential in cardiac hypertrophy treatment.

  • Open Access

    Nanoporous Materials in Biomedical Research: Progress and Potential

    by Fangli Gao, Jianming Xing, Chengzhong Yu

    Nanoporous materials have been the focus of considerable attention due to their unique structural and physicochemical properties and a diverse range of applications, such as drug delivery, biosensing and tissue engineering in biomedical fields. Distinct from existing reviews that primarily focus on material synthesis or single application scenarios, this review provides an integrated and mechanism-oriented overview of nanoporous nanomaterials for biomedical use. This review focuses on the biomedical applications of nanoporous nanomaterials, including inorganic, organic, and hybrid nanoporous materials. Initially, the definition and classification of nanoporous materials are introduced, followed by an overview of their significance in biomedical fields. Importantly, this review systematically summarizes the interactions between nanoporous materials and biological systems at the molecular, cellular, and tissue levels, highlighting the role of nanoporosity in governing biological responses. Further, the biomedical application of nanoporous materials in smart drug and gene delivery, tissue repair and regeneration, immunomodulation, cancer therapy and theranostics are summarized. Finally, key challenges related to biosafety, long-term stability, biodegradation, immune interactions, and clinical translation are critically analyzed, together with emerging trends and future research directions. This review provides an entry-level reference specifically for young researchers working in an exciting interdisciplinary area of nanoporous materials and medicine.


  • Open Access

    Versatile DNA Hydrogel‐Mediated Delivery of Ginsenoside‐Encapsulated Small Extracellular Vesicles to Boost Diabetic Wound Repair

    by Jianming Xing, Shuangyang Li, Yuning Wang, Xushuang Jia, Ruiting Lin, Xintong Liu, Dongxu Wang, Ning Cui, Peng Ji, Jiaqi Chen, et al.

    Diabetic wound healing is often hindered by poor outcomes, prolonged recovery, and high recurrence. To address this, a new therapy approach was demonstrated in this study, in which ginsenoside (GS) molecules are incorporated into small extracellular vesicles (sEV) secreted by mesenchymal stem cells (MSCs), and the formed complexes are then anchored in DNA hydrogels via aptamer‐CD63 affinity as “GS/sEV@DNAgels”. Besides the tissue‐restorative ability that sEVs inherit from MSCs, in GS/sEV@DNAgels, GS molecules provide a superior antimicrobial/anti‐inflammatory environment at wound sites, while DNA hydrogels serve as wound dressings to ensure sustained release kinetics and enhanced skin penetration. An innovative ultrasonic stimulation was developed to promote the massive production of sEVs. By triggering multiple cellular responses that alter membrane fluidity, calcium levels, and relevant protein expression, our approach achieves a 57.7‐fold increase in sEV yield. The synergistic effects of GS and sEVs enhance cell viability, migration, and angiogenesis, as well as local anti‐inflammatory and antibacterial conditions during diabetic wound healing. The upregulation of miR‐424/322 is confirmed as an essential mechanism of this GS/sEV@DNAgel system in accelerating skin restoration. Our work provides a new and promising strategy for diabetic tissue regeneration.


  • Open Access

    Multifunctional extracellular vesicles inhibiting autophagy ameliorate immunotherapy in non-small cell lung cancer

    by Simiao Wang, Jiayi Chen, Yaxin Cui, Jianming Xing, Jiayi Liu, Hao Jiang, Hongqun Yang, Huan Zhang, Man Sun, Jialin Li, et al.


  • Top Cited Papers

    Engineered exosomes for targeted microRNA delivery to reverse liver fibrosis

    by Huan Zhang, Jianming Xing, Man Sun, Yaxin Cui, Yulai Li, Siyuan Hu, Xinhe Wang, Hao Jiang, Yun Zhang, Xuanjie Jiang, et al.


  • Open Access

    Extracellular vesicles for breast cancer diagnosis and therapy

    by Jianan Shi, Huan Zhang, Yaxin Cui, Jianming Xing, Wei Wang, Jiayi Chen, Simiao Wang, Zhaogang Yang